"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 24 | 24 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 28 | 28 |
| 1998 | 0 | 37 | 37 |
| 1999 | 0 | 29 | 29 |
| 2000 | 0 | 47 | 47 |
| 2001 | 0 | 38 | 38 |
| 2002 | 0 | 39 | 39 |
| 2003 | 0 | 56 | 56 |
| 2004 | 0 | 56 | 56 |
| 2005 | 0 | 61 | 61 |
| 2006 | 0 | 77 | 77 |
| 2007 | 0 | 84 | 84 |
| 2008 | 0 | 85 | 85 |
| 2009 | 0 | 94 | 94 |
| 2010 | 0 | 100 | 100 |
| 2011 | 0 | 124 | 124 |
| 2012 | 0 | 101 | 101 |
| 2013 | 1 | 143 | 144 |
| 2014 | 1 | 167 | 168 |
| 2015 | 0 | 159 | 159 |
| 2016 | 4 | 151 | 155 |
| 2017 | 3 | 183 | 186 |
| 2018 | 1 | 201 | 202 |
| 2019 | 1 | 226 | 227 |
| 2020 | 0 | 208 | 208 |
| 2021 | 1 | 122 | 123 |
| 2022 | 0 | 61 | 61 |
| 2023 | 0 | 75 | 75 |
| 2024 | 0 | 120 | 120 |
| 2025 | 0 | 17 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Peripheral T-cell lymphoma-NOS in children and adolescents: a?review from the Children's Oncology Group NHL Committee. Blood Adv. 2025 Mar 25; 9(6):1420-1431.
-
Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatol Commun. 2025 Apr 01; 9(4).
-
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium. Blood Adv. 2025 Mar 11; 9(5):1013-1023.
-
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
-
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review. JAMA Oncol. 2025 Mar 01; 11(3):317-328.
-
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. Haematologica. 2025 Mar 01; 110(3):608-620.
-
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment. Biomark Med. 2025 Mar; 19(6):223-238.
-
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy. Blood Adv. 2025 Feb 25; 9(4):783-792.
-
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia. Hepatol Int. 2025 Feb; 19(1):1-69.
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.